T21 (Risedronate Sodium Delayed-Release 35 mg)
Pill with imprint T21 is White, Elliptical / Oval and has been identified as Risedronate sodium delayed-release 35 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T21
Risedronate sodium delayed-release
- Imprint:
- T21
- Strength:
- 35 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA Inc
- National Drug Code (NDC):
- 00093-5509
More about risedronate
- Risedronate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 28 Reviews
- Drug class: bisphosphonates
Consumer resources
Other brands: Actonel, Atelvia
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
